RxDoctor Payments DataLook up a doctor →

John Altman, MD

Cardiovascular Disease · Lakewood, CONPI 1780680777

Payments from drug & device makers

$796,912in general payments, 2019–2025

Across 858 payments — averaging $928.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cardiovascular Systems Inc.$233K
  • Medtronic$187K
  • Novartis$121K
  • Boston Scientific$120K
  • Philips North America LLC$79K
  • Abbott$38K
  • plus $20K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Cardiovascular Systems Inc.81$233,022
Medtronic(2 entities)88$186,746
Novartis47$120,781
Boston Scientific87$119,628
Philips North America LLC21$78,886
Abbott31$37,768
Abiomed51$3,896
Bard Peripheral Vascular, Inc.5$2,155
Medalliance LLC1$1,972
Amgen76$1,545
Shockwave Medical, Inc36$1,382
E.r. Squibb & Sons, L.L.C.46$896
Johnson & Johnson32$827
Siemens Medical Solutions USA, Inc.6$736
Heartflow, Inc.16$627
Boehringer Ingelheim23$512
Pfizer22$492
Merck21$429
AstraZeneca21$427
Inari Medical, Inc.2$365
Sanofi-aventis U.S. LLC19$322
Impulse Dynamics (USA) Inc.6$316
Edwards Lifesciences4$313
Alnylam Pharmaceuticals Inc.9$232
Baxter Healthcare2$224
Novo Nordisk6$219
Kiniksa Pharmaceuticals, Ltd.11$218
Cvrx, Inc.2$149
Endologix LLC1$138
Esperion Therapeutics, Inc.6$109
W. L. Gore & Associates, Inc.5$107
Scpharmaceuticals Inc.6$103
Angiodynamics, Inc.2$100
Bayer5$85
Chiesi USA, Inc.4$76
Amarin Pharma, Inc.4$76
Otsuka America Pharmaceutical, Inc.4$76
Bridgebio Pharma, Inc.2$68
Kowa Pharmaceuticals America, Inc.5$68
Bardy Diagnostics, Inc.4$67
Lexicon Pharmaceuticals, Inc.4$65
Penumbra, Inc.1$60
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)3$57
Regeneron Healthcare Solutions, Inc.4$56
Microvention, Inc.1$53
Daiichi Sankyo Inc.3$43
Cleerly, Inc.2$38
Kestra Medical Technology Services, Inc.1$35
Astellas Pharma US Inc2$33
Inspire Medical Systems, Inc.2$31
Veryan Medical Incorporated1$25
Ablative Solutions, Inc.1$23
Gilead1$23
Teleflex LLC1$23
Kiniksa Pharmaceuticals International, PLC1$22
Stryker1$22
Z-medica, LLC1$21
Akcea Therapeutics, Inc.1$20
Imperative Care, Inc1$19
Inogen, Inc.1$18

How this compares

$796,912 in reported general payments places this provider in the 95th percentile of 276 cardiovascular disease providers in Colorado.

See all cardiovascular disease providers in Colorado

Medicare billing

Part B allowed, 2024
$430,269
Medicare patients
2,279
Services billed
6,986

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Lakewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →